These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 24589564)

  • 1. Visceral/epicardial adiposity in nonobese and apparently healthy young adults: association with the cardiometabolic profile.
    De Larochellière E; Côté J; Gilbert G; Bibeau K; Ross MK; Dion-Roy V; Pibarot P; Després JP; Larose E
    Atherosclerosis; 2014 May; 234(1):23-9. PubMed ID: 24589564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential association of abdominal, liver, and epicardial adiposity with anthropometry, diabetes, and cardiac remodeling in Asians.
    Lee V; Han Y; Toh DF; Bryant JA; Boubertakh R; Le TT; Chin CWL
    Front Endocrinol (Lausanne); 2024; 15():1439691. PubMed ID: 39257902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between breast adipose tissue, body fat distribution and cardiometabolic risk in women: cross-sectional data and weight-loss intervention.
    Schautz B; Later W; Heller M; Müller MJ; Bosy-Westphal A
    Eur J Clin Nutr; 2011 Jul; 65(7):784-90. PubMed ID: 21427743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac steatosis associates with visceral obesity in nondiabetic obese men.
    Granér M; Siren R; Nyman K; Lundbom J; Hakkarainen A; Pentikäinen MO; Lauerma K; Lundbom N; Adiels M; Nieminen MS; Taskinen MR
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1189-97. PubMed ID: 23418318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of insulin-like growth factor binding protein-2 with metabolic profile and hepatic fat deposition in asymptomatic men and women.
    Rauzier C; Chartrand DJ; Alméras N; Lemieux I; Larose E; Mathieu P; Pibarot P; Lamarche B; Rhéaume C; Poirier P; Després JP; Picard F
    Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E99-E105. PubMed ID: 37285597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of visceral adipose tissue and subcutaneous adipose tissue on metabolic risk factors in middle-aged Japanese.
    Oka R; Miura K; Sakurai M; Nakamura K; Yagi K; Miyamoto S; Moriuchi T; Mabuchi H; Koizumi J; Nomura H; Takeda Y; Inazu A; Nohara A; Kawashiri MA; Nagasawa S; Kobayashi J; Yamagishi M
    Obesity (Silver Spring); 2010 Jan; 18(1):153-60. PubMed ID: 19498348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender Dimorphism in Central Adiposity May Explain Metabolic Dysfunction After Spinal Cord Injury.
    Gorgey AS; Farkas GJ; Dolbow DR; Khalil RE; Gater DR
    PM R; 2018 Apr; 10(4):338-348. PubMed ID: 28827208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study.
    Liu J; Fox CS; Hickson DA; May WD; Hairston KG; Carr JJ; Taylor HA
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5419-26. PubMed ID: 20843952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk.
    Kaess BM; Pedley A; Massaro JM; Murabito J; Hoffmann U; Fox CS
    Diabetologia; 2012 Oct; 55(10):2622-2630. PubMed ID: 22898763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.
    Fox CS; Massaro JM; Hoffmann U; Pou KM; Maurovich-Horvat P; Liu CY; Vasan RS; Murabito JM; Meigs JB; Cupples LA; D'Agostino RB; O'Donnell CJ
    Circulation; 2007 Jul; 116(1):39-48. PubMed ID: 17576866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abdominal visceral and subcutaneous adipose tissue and associations with cardiometabolic risk in Inuit, Africans and Europeans: a cross-sectional study.
    Rønn PF; Andersen GS; Lauritzen T; Christensen DL; Aadahl M; Carstensen B; Grarup N; Jørgensen ME
    BMJ Open; 2020 Sep; 10(9):e038071. PubMed ID: 32928857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents.
    Schusterova I; Leenen FH; Jurko A; Sabol F; Takacova J
    Pediatr Obes; 2014 Feb; 9(1):63-70. PubMed ID: 23504985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of abdominal adiposity, hepatic shear stiffness with subclinical left-ventricular remodeling evaluated by magnetic resonance in adults free of overt cardiovascular diseases: a prospective study.
    Qu Y; Liu J; Li J; Shen S; Chen X; Tang H; Yuan Y; Xia C; Deng L; Chen G; Zheng T; Chen J; Nie L; Yuan F; Tong N; Peng L; Song B
    Cardiovasc Diabetol; 2023 Apr; 22(1):99. PubMed ID: 37120545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Abdominal Visceral Adipose Tissue, Metabolic Health and the Gut Microbiome in Adults.
    U-Din M; Ahmed BA; Syed SA; Ong FJ; Oreskovich SM; Gunn E; Surette MG; Punthakee Z; Steinberg GR; Morrison KM
    J Clin Endocrinol Metab; 2024 Feb; 109(3):680-690. PubMed ID: 37837606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma IGFBP-2 levels reveal heterogeneity in hepatic fat content in adults with excess visceral adiposity.
    Rauzier C; Chartrand DJ; Alméras N; Lemieux I; Larose E; Mathieu P; Pibarot P; Lamarche B; Rhéaume C; Poirier P; Després JP; Picard F
    Front Endocrinol (Lausanne); 2023; 14():1222101. PubMed ID: 37854178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visceral and not subcutaneous abdominal adiposity reduction drives the benefits of a 1-year lifestyle modification program.
    Borel AL; Nazare JA; Smith J; Alméras N; Tremblay A; Bergeron J; Poirier P; Després JP
    Obesity (Silver Spring); 2012 Jun; 20(6):1223-33. PubMed ID: 22262155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epicardial fat, abdominal adiposity and insulin resistance in obese pre-pubertal and early pubertal children.
    Manco M; Morandi A; Marigliano M; Rigotti F; Manfredi R; Maffeis C
    Atherosclerosis; 2013 Feb; 226(2):490-5. PubMed ID: 23261169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of adiposity evaluated by anthropometric, BIA, and DXA measures with cardiometabolic risk factors in nonobese postmenopausal women: the CoLaus/OsteoLaus cohort.
    Stamm E; Marques-Vidal P; Rodriguez EG; Vollenweider P; Hans D; Lamy O
    Menopause; 2022 Jan; 29(4):450-459. PubMed ID: 35357367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body adiposity indicators and cardiometabolic risk: Cross-sectional analysis in participants from the PREDIMED-Plus trial.
    Konieczna J; Abete I; Galmés AM; Babio N; Colom A; Zulet MA; Estruch R; Vidal J; Toledo E; Díaz-López A; Fiol M; Casas R; Vera J; Buil-Cosiales P; Martín V; Goday A; Salas-Salvadó J; Martínez JA; Romaguera D;
    Clin Nutr; 2019 Aug; 38(4):1883-1891. PubMed ID: 30031660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral and subcutaneous fat quality and cardiometabolic risk.
    Rosenquist KJ; Pedley A; Massaro JM; Therkelsen KE; Murabito JM; Hoffmann U; Fox CS
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):762-71. PubMed ID: 23664720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.